Bovine spongiform encephalopathy in Japan: History and recent studies on oxidative stress in prion diseases

Microbiology and Immunology

Volumn 50, Issue 8, 2006, Pages 565-578

  Onodera, Takashi ^a   Sakudo, Akikazu ^a,b   Wu, Guoying ^a   Saeki, Keiichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Apoptosis; BSE; Prion disease; Prion protein

Indexed keywords

PRION PROTEIN;

APOPTOSIS; BOVINE SPONGIFORM ENCEPHALOPATHY; CELL FUNCTION; CELL MATURATION; DISEASE CONTROL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDING; GENE TARGETING; INOCULATION; JAPAN; LIVESTOCK; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRION DISEASE; REVIEW; RISK FACTOR; UNITED KINGDOM; WESTERN BLOTTING;

ANIMALIA; BOS TAURUS; BOVINE SPONGIFORM ENCEPHALOPATHY PRION; CRICETINAE; MAMMALIA; OVIS ARIES;

EID: 33747865458     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2006.tb03831.x     Document Type: Review

References (141)

1. Alpers, M. 1970. Kuru in New Guinea: its changing pattern and etiologic elucidation. Am. J. Trop. Med. Hyg. 19: 133-137.
2. Basler, K., Oesch, B., Scott, M., Westaway, D., Walchli, M., Groth, D.F., Mckinley, M.P., Prusiner, S.B., and Weissmann, C. 1986. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46: 417-428.
3. Bendheim, P.E., Brown, H.R., Rudelli, R.D., Scala, L.J., Goller, N.L., Wen, G.Y., Kascsak, R.J., Cashman, N.R., and Bolton, D.C. 1992. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 42: 149-156.
4. Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C., and Aguzzi, A. 1996. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379: 339-343.
5. Brown, D.R. 1999. Prion protein expression aids cellular uptake and veratridine-induced release of copper. J. Neurosci. Res. 58: 717-725.
6. Sc-like prion protein peptide inhibits the function of cellular prion protein. Biochem. J. 352: 511-518.
7. Brown, D.R., and Besinger, A. 1998. Prion protein expression and superoxide dismutase activity. Biochem. J. 334: 423-429.
8. Brown, D.R., Qin K., Herms, J.W., Madlung, A., Manson, J., Strome, R., Fraser, P.E., Kruck, T., von Bohlen, A., Schulz-Schaeffer, W., Giese, A., Westaway, D., and Kretzschmar, H. 1997. The cellular prion protein binds copper in vivo. Nature 390: 684-687.
9. Brown, D.R., Wong, B.S., Hafiz, F., Clive, C., Haswell, S.J., and Jones, I.M. 1999. Normal prion protein has an activity like that of superoxide dismutase. Biochem. J. 344: 1-5.
10. Brown, P., Gibbs, C.J., Jr., Rogers Johnson, P., Asher, D.M., Sulima, M.P., Bacote, A., Goldfarb, L.G., and Gajdusek, D.C. 1994. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted diseases. Ann. Neurol. 35: 513-529.
11. Brown, P., Will, R.G., Bradley, R., Asher, D.M., and Detwiler, L. 2001. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob Disease: background evolution and current concerns. Emerg. Infect. Dis. 7: 6-16.
12. Bueler, H., Aguzzi, A., Sailer, A., Greiner, R.A., Autenried, P., Agnet, M., and Weissmann, C. 1993. Mice devoid of PrP are resistant to scrapie. Cell 73: 1339-1347.
13. Bueler, H., Fischer, M., Lang, Y., Blutemann, H., Lipp, H.P., DeArmond, S.J., Prusiner, S.B., Agnet, M., and Weissmann, C. 1992. Normal development and behavior of mice lacking the neuronal cell-surface PrP protein. Nature 356: 577-582.
14. Caughey, B., Race, R.E., and Chesebro, B. 1988. Detection of prion protein mRNA in normal and scrapie-infected tissues and cell lines. J. Gen. Virol. 69: 711-716.
15. Chesebro, B., Race, R., Wehrly, K., Nishio, J., Bloon, M., Lechmer, D., et al. 1985. Identitfication of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature 315: 331-333.
16. Creutzfeldt, H.G. 1920. Über eine eigenartige herdhomige Erkrankung des Zentralnervensystems. Zeitschrift für die Gesamte Neurologie und Psychiatrie 57: 1-18.
17. Cui, T., Daniels, M., Wong, B.S., Li, R., Sy, M.S., Sassoon, J., and Brown, D.R. 2003. Mapping the functional domain of the prion protein. Eur. J. Biochem. 270: 3368-3376.
18. Cuille, J., and Chelle, P.L. 1938. La tremblante du mouton est bien inoculable. C. R. Acad. Sci. (Paris) 206: 78-79.
19. Cyranoski, D. 2001. Japan's first BSE case fuels fears else-where. Nature 413: 337.
20. Dodelet, V.C., and Cashman, N.R. 1998. Prion protein expression in human leukocyte differentiation. Blood 91: 1556-1561.
21. Sc interacts with molecular chaperones of the Hsp60 family. J. Virol. 70: 4724-4728.
22. Eng, L.F., and Ghirnikar, R.S. 1994. GFAP and astrogliosis. Brain Pathol. 4: 229-237.
23. Sc) in nervous and lymphoid tissues of sheep with sub-clinical scrapie. Vet. Pathol. 40: 164-174.
24. Gajdusek, D.C., Gibbs, C.J., and Alpers, M. 1966. Experimental 'kuru' in chimpanzees: a pathological report. Lancet ii, 1056-1059.
25. Gajdusek, D.C., Gibbs, C.J., and Alpers, M. 1966. Experimental transmission of kuru-like syndrome to chimpanzees. Nature 209: 794-796.
26. Giese, A., Brown, D.R., Groschup, M.H., Feldmann, C., Haist, I., and Kretzschmar, H.A. 1998. Role of microglia in neuronal cell death in prion disease. Brain Pathol. 8: 449-457.
27. Gonzalez-Iglesias, R., Pajares, M.A., Ocal, C., Espinosa, J.C., Oesch, B., and Gasset, M. 2002. Prion protein interaction with glycosaminoglycan occurs with the formation of oligomeric complexes stabilized by Cu(II) bridges. J. Mol. Biol. 319: 527-540.
28. Graner, E., Mercadante, A.F., Zanata, S.M., Forlenza, O.V., Cabral, A.L., Veiga, S.S., Juliano, M.A., Roesler, R., Walz, R., Minetti, A., Izquierdo, I., Martins, V.R., and Brentani, R.R. 2000. Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res. Mol. Brain Res.76: 85-92.
29. Graner, E., Mercadante, A.F., Zanata, S.M., Martins, V.R., Jay, D.G., and Brentani, R.R. 2000. Laminin-induced PC-12 cell differentiation is inhibited following laser inactivation of cellular prion protein. FEBS Lett. 482: 257-260.
30. Hadlow, W.J. 1959. Scrapie and kuru. Lancet ii: 289-290.
31. Haigh, C.L., Edwards, K., and Brown, D.R. 2005. Copper binding is the governing determinant of prion protein turnover. Mol. Cell. Neurosci. 30: 186-196.
32. Hainfellner, J.A., Parchi, P., Kitamoto, T., Jarius, C., Gambetti, P., and Budka, H. 1999. A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein. Ann. Neurol. 45: 812-816.
33. Hashimoto, A., Onodera, T., Ikeda, H., and Kitani, H. 2000. Isolation and characterization of fetal bovine brain cells in primary culture. Res. Vet. Sci. 69: 39-46.
34. Harris, D.A., Lele, P., and Snider, W.D. 1993. Localization of the mRNA for a chicken prion protein by in situ hybridization. Proc. Natl. Acad. Sci. U.S.A. 90: 4309-4313.
35. Hill, A.F., Joiner, S., Wadsworth, J.D., Sidle, K.C., Bell, J.E., Budka, H., Ironside, J.W., and Collinge, J. 2003. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126: 1333-1346.
36. Hornshaw, M.P., McDermott, J.R., and Candy, J.M. 1995. Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem. Biophys. Res. Commun. 207: 621-629.
37. Hsiao, K.K., Scott, M., Foster, D., Groth, D.F., DeArmond, S.J., and Prusiner, S.B.1990. Spontaneous neurodegeneration transgenic mice with mutant prion protein. Science 250: 1587-1590.
38. Jakob, A. 1921. Über eigenartige Erkrankugen des Zentralnervensystems mit bemerkenswertem anatomischen Befund. Zeitschrift für die Gesamte Neurologie und Psychiatrie 64: 147-228.
39. Jakob, A. 1921. Über eigenartige Erkrankugen des Zentralnervensystems mit bemerkenswertem anatomischen Befund. Deutsche Zeitschrift für Nervenheilkunde 20: 132-146.
40. Jakob, A. 1921. Über eine der multiplen Sklerose klinisch nachestehende Erkrankung des Zentralnervensystems (spastische Pseudosklerose) mit bemerkenswertem anatomischen Befund. Medizinische Klinik 13: 372-376.
41. Kanaani, J., Prusiner, S. B., Diacovo, J., Baekkeskov, S., and Legname, G. 2005. Recombinant prion protein induces rapid polarization and development of synapses in embryonic rat hippocampal neurons in vitro. J. Neurochem. 95: 1373-1386.
42. Kimura, K.M., Haritani, M., Kubo, M., Hayakawa, S., and Ikeda, A. 2002. Histopathological and immunohistochemical evaluation of the first case of BSE in Japan. Vet. Rec. 151: 328-330.
43. Klamt, F., Dal-Pizzol, F., Conte da Frota, M.L., Walz, R., Andrades, M.E., da Silva, E.G., Brentani, R.R., Izquierdo, I., and Fonseca Moreira, J.C. 2001. Imbalance of antioxidant defense in mice lacking cellular prion protein. Free Radic. Biol. Med. 30: 1137-1144.
44. Klatzo, I., Gajdusek, D.C., and Zigas, V. 1959. Pathology of kuru. Lab. Invest. 8: 799-874.
45. Kramer, M.L., Kratzin, H.D., Schmidt, B., Römer, A., Windl, O., Liemann, S., Hornemann, S., and Kretzschmar, H. 2001. Prion protein binds copper within the physiological concentration range. J. Biol. Chem. 276: 16711-16719.
46. Kretzschmar, H.A., Prusiner, S.B., Stowring, L.E., and DeArmond, S.J. 1986. Scrapie prion proteins are synthesized in neurons. Am. J. Pathol. 122: 1-5.
47. Kretzschmar, H.A., Tings, T., Madlung, A., Giese, A., and Herms, J. 2000. Function of PrP(C) as a copper-binding protein at the synapse. Arch. Virol. 16: suppl. 239-249.
48. Kubosaki, A., Nishimura-Nasu, Y., Nishimura, T., Yusa, S., Sakudo, A., Saeki, K., Matsumoto, Y., Itohara, S., and Onodera, T. 2003. Expression of normal cellular prion protein (PrP(c)) on T lymphocytes and the effect of copper ion: analysis by wild-type and prion protein gene-deficient mice. Biochem. Biophys. Res. Commun. 307: 810-813.
49. Kubosaki, A., Ueno, A., Matsumoto, Y., Doi, K., Saeki, K., and Onodera, T. 2000. Analysis of prion protein mRNA by in situ hybridization in brain and placenta of sheep. Biochem. Biophys. Res. Commun. 273: 890-893.
50. Kubosaki, A., Yusa, S., Nasu, Y., Nishimura, T., Nakamura, Y., Saeki, K., Matsumoto, Y., Itohara, S., and Onodera, T. 2001. Distribution of cellular isoform of prion protein in T lymphocytes and bone marrow, analyzed by wild-type and prion protein gene-deficient mice. Biochem. Biophys. Res. Commun. 282: 103-107.
51. Kurschner, C., and Morgan, J.I. 1995. The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system. Brain Res. Mol. Brain Res. 30: 165-168.
52. Kuwahara, C., Takeuchi, A.M., Nishimura, T., Haraguchi, K., Kubosaki, A., Matsumoto, Y., Saeki, K., Matsumoto, Y., Yokoyama, T., Itohara, S., and Onodera, T. 1999. Prions prevent neuronal cell-line death. Nature 400: 225-226.
53. Lassle, M., Blatch, G.L., Kundra, V., Takatori, T., and Zetter, B.R. 1997. Characterization of binding domains for heat shock proteins and in vitro phosphorylation by different kinases. J. Biol. Chem. 272: 1876-1884.
54. Lee, D.C., Sakudo, A., Kim, C.K., Nishimura, T., Saeki, K., Matsumoto, Y., Yokoyama, T., Chen, S.G., Itohara, S., and Onodera, T. 2006. Fusion of doppel to octapeptide repeat and N-terminal half of hydrophobic region of prion protein confers resistance to serum deprivation. Microbiol. Immunol. 50: 203-209.
55. Li, A., Sakaguchi, S., Atarashi, R., Roy, B.C., Nakaoke, R., Arima, K., Okimura, N., Kopacek, J., and Shigematsu, K. 2000. Identification of a novel gene encoding a PrP-like protein expressed as chimeric transcripts fused to PrP exon 1/2 in ataxic mouse line with a disrupted PrP gene. Cell. Mol. Neurobiol. 20: 553-567.
56. Li, R., Liu, D., Zanusso, G., Liu, T., Fayen, J.D., Huang, J.H., Petersen, R.B., Gambetti, P., and Sy, M.S. 2001. The expression and potential function of cellular prion protein in human lymphocytes. Cell. Immunol. 207: 49-58.
57. Lopes, M.H., Hajj, G.N., Muras, A.G., Mancini, G.L., Castro, R.M., Ribeiro, K.C., Brentani, R.R., Linden, R., and Martins, V.R. 2005. Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J. Neurosci. 25: 11330-11339.
58. Mange, A., Beranger, F., Peoc'h, K., Onodera, T., Frobert, Y., and Lehmann, S. 2004. Alpha- and beta-cleavages of the amino-terminus of the cellular prion protein. Biol. Cell 96: 125-132.
59. Manson, J.C., Clarke, A.R., Hooper, M.L., Aitchison, L., McConnell, I., and Hope, J. 1994. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol. Neurobiol. 8: 121-127.
60. Manson, J.C., Clarke, A.R., McBride, P.A., McConnell, I., and Hope, J. 1994. PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 3: 331-340.
61. Matucci, A., Zanusso, G., Gelati, M., Farinazzo, A., Fiorini, M., Ferrari, S., Andrighetto, G., Cestari, T., Caramelli, M., Negro, A., Morbin, M., Chiesa, R., Monaco, S., and Tridente, G. 2005. Analysis of mammalian scrapie protein by novel monoclonal antibodies recognizing distinct prion protein glycoforms: an immunoblot and immunohistochemical study at the light and electron microscopic levels. Brain Res. Bull. 65: 155-162.
62. Meggio, F., Negro, A., Sarno, S., Ruzzene, M., Bertoli, A., Sorgato, M.C., and Pinna, L.A. 2000. Bovine prion protein as a modulator of protein kinase CK2. Biochem. J. 352: 191-196.
63. Miura, T., Hori-i, A., Mototani, H., and Takeuchi, H. 1999. Raman spectroscopic study on the copper(II) binding mode of prion octapeptide and its pH dependence. Biochemistry 38: 11560-11569.
64. Mizoi, S., Yoshino, T., Momotani, E., Kubosaki, A., Nakamura, Y., and Onodera, T. 1999. Exacerbated spongiform lesions in the cerebral cortex in Japanese sheep, in an out-brake of scrapie during 1984-1987. Jpn. J. Infect. Dis. 52: 242-244.
65. Moore, R.C., Lee, I.Y., Silverman, G.L., Harrison, P.M., Strome, R., Heinrich, C., Karunaratne, A., Pasternak, S.H., Chishti, M.A., Liang, Y., Mastrangelo, P., Wang, K., Smit, A.F., Katamine, S., Carlson, G.A., Cohen, F.E., Prusiner, S.B., Melton, D.W., Tremblay, P., Hood, L.E., and West-away, D. 1999. Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J. Mol. Biol. 292: 797-817.
66. Moser, M., Colello, R.J., Pott, U., and Oesch, B. 1995. Developmental expression of the prion protein gene in glial cells. Neuron 14: 509-517.
67. Mouillet-Richard, S., Ermonval, M., Chebassier, C., Laplanche, J.L., Lehmann, S., Launay, J.M., and Kellermann, O. 2000. Signal transduction through prion protein. Science 289: 1925-1928.
68. Mouillet-Richard, S., Pietri, M., Schneider, B., Vidal, C., Mutel, V., Launay, J.M., and Kellermann, O. 2005. Modulation of serotonergic receptor signaling and cross-talk by prion protein. J. Biol. Chem. 280: 4592-4601.
69. Muramatsu, Y., Tanaka, K., Horiuchi, M., Ishiguro, N., Shinagawa, M., Matsui, T., and Onodera, T. 1992. A specific RFLP type associated with the occurrence of sheep scrapie in Japan. Arch. Virol. 127: 1-9.
70. Nieznanski, K., Nieznanska, H., Skowronek, K.J., Osiecka, K.M., and Stepkowski, D. 2005. Direct interaction between prion protein and tubulin. Biochem. Biophys. Res. Commun. 334: 403-411.
71. Nishida, N., Tremblay, P., Sugimoto, T., Shigematsu, K., Shirabe, S., Petromilli, C., Erpel, S.P., Nakaoke, R., Atarashi, R., Houtani, T., Torchia, M., Sakaguchi, S., DeArmond, S.J., Prusiner, S.B., and Katamine, S. 1999. A mouse prion protein transgene rescues mice deficient for the prion protein gene from Purkinje cell degeneration and demyelination. Lab. Invest. 79: 689-697.
72. Nishimura, T., Sakudo, A., Nakamura, I., Lee, D.C., Taniuchi, Y., Saeki, K., Matsumoto, Y., Ogawa, M., Sakaguchi, S., Itohara, S., and Onodera, T. 2004. Cellular prion protein regulates intracellular hydrogen peroxide level and prevents copper-induced apoptosis. Biochem. Biophys. Res. Commun. 323: 218-222.
73. Sc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J. Biol. Chem. 279: 16797-16804.
74. Oesch, B., Westaway, D., Walchli, M., McKinley, M.P., Kent, S.B., Aebersold, R., Barry, R.A., Tempst, P., Teplow, D.B., Hood, L.E., Prusiner, S.B., and Weissmann, C. 1985. A cellular gene encodes scrapie PrP 27-30 protein. Cell 40: 735-746.
75. Onodera, T., Haritani, M., Narita, M., and Nakagawa, M. 1990. Epidemiology of ovine scrapie in Japan. J. Agric. Res. Quart. 24: 216-218.
76. Onodera, T., and Hayashi, T. 1994. Diversity of clinical signs in natural scrapie in Japan. J. Agric. Res. Quart. 28: 59-61.
77. Onodera, T., Ikeda, T., Muramatsu, Y., and Shinagawa, M. 1993. Isolation of scrapie agent from the placenta of sheep with natural scrapie in Japan. Microbiol. Immunol. 37: 311-316.
78. Onodera, T., and Kim, C.K. 2006. BSE situation and establishment of Food Safety Commission in Japan. J. Vet. Sci. 7: 1-11.
79. Onodera, T., Momotani, E., Shimizu, S., Yoshihara, K., and Yoshino, T. 1990. Histopathology and image analysis of the brain lesions in ovine scrapie in Japan. Jpn. J. Vet. Sci. 52: 439-442.
80. Onodera, T., and Saeki, K. 2000. Japanese scrapie cases. Jpn. J. Infect. Dis. 53: 56-61.
81. Pan, K.-M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., Mehlhr, I., Huang, Z., Fletterick, R.J., Cohen, F.E., and Prusiner, S.B. 1993. Conversion of α-helices β-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. U.S.A. 90:10962-10966.
82. Parchi, P., Castellani, R., Capellari, S., Ghetti, B., Young, K., Chen, S.G., Farlow, M., Dickson, D.W., Sima, A.A., Trojanowski, J.Q., Petersen, R.B., and Gambetti, P. 1996. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob Disease. Ann. Neurol. 39: 767-778.
83. Parchi, P., Giese, A., Capellari, S., Brown, P., Schultz-Schaeffer, W., Windl, O., Zerr, I., Budka, H., Kopp, N., Picardo, P., Poser, S., Rojiani, A., Streichemberger, N., Julien, J., Vital, C., Ghetti, B., Gambetti, P., and Kretzschmar, H. 1999. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 46: 224-233.
84. Park, J.S., Onodera, T., Nishimura, S., Thompson, R.F., and Itohara, S. 2006. Molecular evidence for two-stage learning and partial laterality in eyeblink conditioning of mice. Proc. Natl. Acad. Sci. U.S.A. 103: 5549-5554.
85. Pattison, I.H., Gordon, W., and Millson, G. 1959. Experimental production of scrapie in goats. J. Comp. Pathol. 69: 300-312.
86. Pattison, I.H., and Jebbett, J.N. 1973. Clinical and histological recovery from the scrapie-like spongiform encephalopathy produced in mice by feeding them with cuprizone. J. Pathol. 109: 245-250.
87. Pauly, P.C., and Harris, D.A. 1998. Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273: 33107-33110.
88. Pouti, G., Giaccone, G., Rossi, G., Canciani, B., Bugiani, O., and Tagliavini, F. 1999. Sporadic Creutzfeldt-Jakob disease: co-occurrent of different types of PrP(Sc) in the same brain. Neurology 53: 2173-2176.
89. Prusiner, S.B. 1997. Prion diseases and BSE crisis. Science 278: 245-251.
90. Prusiner, S.B., Bolton, D.C., Groth, D.F., Bowman, K.A., Coheran, S.P., and Mckinley, M.P. 1982. Further purification and characterization of scrapie prions. Biochemistry 21: 6942-6950.
91. Prusiner, S.B., Groth, D., Serban, A., Koehler, R., Foster, D., Torchia, M., Burton, D., Yang, S.L., and DeArmond, S.J. 1993. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc. Natl. Acad. Sci. U.S.A. 90: 10608-10612.
92. Rachidi, W., Vilette, D., Guiraud, P., Arlotto, M., Riondel, J., Laude, H., Lehmann, S., and Favier, A. 2003. Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J. Biol. Chem. 278: 9064-9072.
93. Rieger, R., Edenhofer, F., Lasmézas, C.I., and Weiss, S. 1997. The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat. Med. 3: 1383-1388.
94. Robakis, N.K., Devine-Gage, E.A., Jenkins, E.C., Kascsak, R.J., Brown, W.T., Krawczun, M.S., and Silvermann, W.P. 1986. Localization of human gene homologous to the PrP gene on the parm of chromosome 20 and detection of PrP-related antigens in normal human brain. Biochem. Biophys. Res. Commun. 140: 758-765.
95. Rossi, D., Cozzio, A., Flechsig, E., Klein, M.A., Rulicke, T., Aguzzi, A., and Weissmann, C. 2001. Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain. EMBO J. 20: 694-702.
96. Saeki, K., Matsumoto, Y., Hirota, Y., Matsumoto, Y., and Onodera, T. 1996. Three-exon structure of the gene encoding the rat prion protein and its expression in tissues. Virus Genes 12: 15-20.
97. Sakaguchi, S., Katamine, S., Nishida, N., Moriuchi, R., Shigematsu, K., Sugimoto, T., Nakatani, A., Kataoka, Y., Houtani, T., Shirabe, S., Okada, H., Hasegawa, S., Miyamoto, T., and Noda, T. 1996. Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380: 528-531.
98. Sakudo, A., Lee, D.C., Li, S., Nakamura, T., Matsumoto, Y., Saeki, K., Itohara, S., Ikuta, K., and Onodera, T. 2005. PrP cooperates with STI1 to regulate SOD activity in PrP-deficient neuronal cell line. Biochem. Biophys. Res. Commun. 328: 14-19.
99. Sakudo, A., Lee, D.C., Nakamura, I., Taniuchi, Y., Saeki, K., Matsumoto, Y., Itohara, S., Ikuta, K., and Onodera, T. 2005. Cell-automonous PrP-Doppel interaction regulates apoptosis in PrP gene-deficient neuronal cells. Boichem. Biophys. Res. Commun. 333: 448-454.
100. Sakudo, A., Lee, D.C., Nishimura, T., Li, S., Tsuji, S., Nakamura, T., Matsumoto, Y., Saeki, K., Itohara, S., Ikuta, K., and Onodera, T. 2005. Octapeptide repeat region and N-terminal half of hydrophobic region of prion protein (PrP) mediate PrP-dependent activation of superoxide dismutase. Biochem. Biophys. Res. Commun. 326: 600-606.
101. Sakudo, A., Lee, D.C., Saeki, K., Nakamura, Y., Inoue, K., Matsumoto, Y., Itohara, S., and Onodera, T. 2003. Impairment of superoxide dismutase activation by N-terminally truncated prion protein (PrP) in PrP-deficient neuronal cell line. Biochem. Biophys. Res. Commun. 308: 660-667.
102. Sakudo, A., Lee, D.C., Yoshimura, E., Nagasaka, S., Nitta, K., Saeki, K., Matsumoto, Y., Lehmann, S., Itohara, S., Sakaguchi, S., and Onodera, T. 2004. Prion protein suppresses perturbation of cellular copper homeostasis under oxidative conditions. Biochem. Biophys. Res. Commun. 313: 850-855.
103. Sakudo, A., Onodera, T., Suganuma, Y., Kobayashi, T., Saeki, K., and Ikuta, K. 2006. Recent advances in clarifying prion protein functions using knockout mice and derived cell lines (Review). Mini-Rev. Med. Chem. 6: 589-601.
104. Schatzl, H.M., Da Costa, M., Taylor, L., Cohen, F.E., and Prusiner, S.B. 1995. Prion protein gene variation among primates. J. Mol. Biol. 245: 362-374.
105. Schmitt-Ulms, G., Legname, G., Baldwin, M.A., Ball, H.L., Bradon, N., Bosque, P.J., Crossin, K.L., Edelman, G.M., DeArmond, S.J., Cohen, F.E., and Prusiner, S.B. 2001. Binding of neural cell adhesion molecules (NCAMs) to the cellular prion protein. J. Mol. Biol. 314: 1209-1225.
106. Schneider, B., Mutel, V., Pietri, M., Ermonval, M., Mouillet-Richard, S., and Kellermann, O. 2003 NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells. Proc. Natl. Acad. Sci. U.S.A. 100: 13326-13331.
107. Seo, S.W., Hara, K., Kubosaki, A., Nasu, Y., Nishimura, T., Saeki, K., Matsumoto, Y., Endo, H., and Onodera, T. 2002. Comparative analysis of the prion protein open reading frame nucleotide sequences of two ruminants, the moufflon and golden takin. Intervirology 44: 359-363.
108. Shaked, Y., Rosenmann, H., Talmor, G., and Gabizon, R. 1999. A C-terminal-truncated PrP isoform is present in mature sperm. J. Biol. Chem. 274: 32153-32158.
109. Shyu, W.C., Chen, C.P., Saeki, K., Kubosaki, A., Matsumoto, Y., Onodera, T., Ding, D.C., Chiang, M.F., Lee, Y.J., Lin, S.Z., and Li, H. 2005. Hypoglycemia enhances the expression of prion protein and heat-shock protein 70 in a mouse neuroblastoma cell line. J. Neurosci. Res. 80: 887-894.
110. Spielhaupter, C., and Schatzl, H.M. 2001. PrPC directly interacts with proteins involved in signaling pathways. J. Biol. Chem. 276: 44604-44612.
111. c) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. Proc. Natl. Acad. Sci. U.S.A. 103: 3416-3421.
112. Sugiura, K. 2004. Risk of induction of BSE into Japan by the historical importation of cattle from the United Kingdom and Gremany. Prev. Vet. Med. 64: 191-200.
113. Sugiura, K., Ito, K., Yokoyama, T., Kumagai, S., and Onodera, T. 2003. A model to assess the risk of the introduction into Japan of the bovine spongiform encephalopathy agent through imported animals, meat and meat-and-bone meal. OIE Rev. Sci. Tech. 22: 777-794.
114. Tabaton, M., Monaco, S., Cordone, M.P., Colucci, M., Giaccone, G., Tagliavini, F., and Zanusso, G. 2004. Prion deposition in olfactory biopsy of sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 55: 294-296.
115. c mRNA by in situ hybridization in brain, placenta, uterus and testis of rats. Intervirology 38: 309-315.
116. Taraboulos, A., Raeber, A.J., Borchelt, D.R., Serban, D., and Prusiner, S.B. 1992. Synthesis and trafficking of prion proteins in cultured cells. Mol. Biol. Cell 3: 851-863.
117. Tateishi, J., Koga, M., and Mori, R. 1981. Experimental transmission of Creutzfeldt-Jakob disease. Acta Pathol. Jpn. 31: 943-951.
118. Truchot, L., Bencsik, A., Perret-Liaudet, A., Biacabe, A.G., Richard, M., Ironside, J., Kopp, N., and Streichenberger, N. 2004. Quantitative study of spongiform change in putamen of 24 case of Creutzfeldt-Jakob disease. J. Neuropahol. Exp. Neurol. 63: 193-198.
119. Tsutsui, T., and Kasuga, F. 2006. Assessment of the impact of cattle testing strategies on human exposure to BSE agents in Japan. Int. J. Food Microbiol. 107: 256-264.
120. Tsutsui, T., Yamane, I., and Shimura, K. 2004. Preliminary evaluation of the prevalence of BSE in Japan. Vet. Rec. 154: 113-114.
121. Vassallo, N., Herms, J., Behrens, C., Krebs, B., Saeki, K., Onodera, T., Windl, O., and Kretzschmar, H.A. 2005. Activation of phosphatidylinositol 3-kinase by cellular prion protein and its role in cell survival. Biochem. Biophys. Res. Commun. 332: 75-82.
122. Viles, J.H., Cohen, F.E., Prusiner, S.B., Goodin, D.B., Wright, P.E., and Dyson, H.J. 1999. Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc. Natl. Acad. Sci. U.S.A. 96: 2042-2047.
123. Watts, J. 2001. Tokyo Japan's government tries to allay BSE fears. Lancet 358: 2057.
124. Weise, J., Sandau, R., Schwarting, S., Crome, O., Wrede, A., Schulz-Schaeffer, W., Zerr, I., and Bähr, M. 2006. Deletion of cellular prion protein results in reduced akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injury. Stroke 37: 1296-1300.
125. Weissmann, C., and Flechsig, E. 2003. PrP knock-out and PrP transgenic mice in prion research. Br. Med. Bull. Rev. 66: 43-60.
126. Wilesmith, J.W., Ryan, J.B.M., and Atkinson, M.J. 1991. Bovine spongiform encephalopathy: epidemiological studies of the origin. Vet. Rec. 128: 199-203.
127. Wells, G.A.H., Scott, A.C., Johnson, C.T., Gunning, R.F., Hancock, R.D., Jeffrey, M., Dawson, M., and Bradley, R. 1987. A novel progressive spongiform encephalopathy in cattle. Vet. Rec. 212: 419-420.
128. Wong, B.S., Liu, T., Li, R., Pan, T., Petersen, R.B., Smith, M.A., Gambetti, P., Perry, G., Manson, J.C., Brown, D.R., and Sy, M.S. 2001. Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J. Neurochem. 76: 565-572.
129. Wong, B.S., Liu, T., Paisley, D., Li, R., Pan, T., Chen, S.G., Perry, G., Petersen, R.B., Smith, M.A., Melton, D.W., Gambetti, P., Brown, D.R., and Sy, M.S. 2001. Induction of HO-1 and NOS in doppel-expressing mice devoid of PrP: implications for doppel function. Mol. Cell. Neurosci. 17: 768-775.
130. Wong, B.S., Pan, T., Liu, T., Li, R., Petersen, R.B., Jones, I.M., Gambetti, P., Brown, D.R., and Sy, M.S. 2000. Prion disease: a loss of antioxidant function? Biochem. Biophys. Res. Commun. 275: 249-252.
131. Wopfner, F., Weidenhofer, G., Schneider, R., Von Brunn, A., Gilch, S., Schwarz, T.F., Werner, T., and Schatzl, H.M. 1999. Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J. Mol. Biol. 289: 1163-1178.
132. Yehiely, F., Bamborough, P., Da Costa, M., Perry, B.J., Thinakaran, G., Cohen, F.E., Carlson, G.A., and Prusiner, S.B.1997. Identification of candidate proteins binding to prion protein. Neurobiol. Dis. 3: 339-355.
133. Yokoyama, T., Kimura, K.M., Ushiki, Y., Yamada, S., Morooka, A., Nakashiba, T., Sassa, T., and Itohara, S. 2001. In vivo conversion of cellular prion protein to pathogenic isoforms, as monitored by conformation-specific antibodies. J. Biol. Chem. 276: 11265-11271.
134. Zanata, S.M., Lopes, M.H., Mercadante, A.F., Hajj, G.N., Chiarini, L.B., Nomizo, R., Freitas, A.R., Cabral, A.L., Lee, K.S., Juliano, M.A., de Oliveira, E., Jachieri, S.G., Burlingame, A., Huang, L., Linden, R., Brentani, R.R., and Martins, V.R. 2002. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J. 21: 3307-3316.
135. Zanusso, G., Casalone, C., Acutis, P., Bozzetta, E., Farinazzo, A., Gelati, M., Fiorini, M., Forloni, G., Sy, M.S., Monaco, S., and Caramelli, M. 2003. Molecular analysis of iatrogenic scrapie in Italy. J. Gen. Virol. 84: 1047-1052.
136. Zanusso, G., Farinazzo, A., Fiorini, M., Gelati, M., Castagna, A., Righetti, P.G., Rizzuto, N., and Monaco, S. 2001. pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease. J. Biol. Chem. 276: 40377-40380.
137. Zanusso, G., Farinazzo, A., Prelli, F., Fiorini, M., Gelati, M., Ferrari, S., Righetti, P.G., Rizzuto, N., Frangione, B., and Monaco, S. 2004. Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes. J. Biol. Chem. 279: 38936-38942.
138. Zanusso, G., Vattemi, G., Ferrari, S., Tabaton, M., Pecini, E., Cavallaro, T., Tomelleri, G., Filosto, M., Tonin, P., Nardelli, E., Rizzuto, N., and Monaco, S. 2001. Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy. Brain Pathol. 11: 182-189.
139. Zeng, F., Watt, N.T., Walmsley, A.R., and Hooper, N.M. 2003. Tethering the N-terminus of the prion protein compromises the cellular response to oxidative stress. J. Neurochem. 84: 480-490.
140. Zhang, C.C., Steele, A.D., Lindquist, S., and Lodish, H.F. 2006. Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal. Proc. Natl. Acad. Sci. U.S.A. 103: 2184-2189.
141. Zigas, V., and Gajdusek, D.C. 1957. Kuru: clinical study of a new syndrome resembling paralysis agitans in natives of the Eastern Highlands of Australian New Guinea. Med. J. Australia 2: 745-754.